Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18379871rdf:typepubmed:Citationlld:pubmed
pubmed-article:18379871lifeskim:mentionsumls-concept:C0025286lld:lifeskim
pubmed-article:18379871lifeskim:mentionsumls-concept:C0174680lld:lifeskim
pubmed-article:18379871lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:18379871pubmed:issue6lld:pubmed
pubmed-article:18379871pubmed:dateCreated2008-9-29lld:pubmed
pubmed-article:18379871pubmed:abstractTextCyclin D1 is an important nuclear protein required for progression of cells through the G1 phase of the cell cycle. The proliferative potential of meningiomas has been studied using various proliferative markers. However, there have been only few published studies evaluating Cyclin D1 immunoreactivity in meningiomas.lld:pubmed
pubmed-article:18379871pubmed:languageenglld:pubmed
pubmed-article:18379871pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18379871pubmed:citationSubsetIMlld:pubmed
pubmed-article:18379871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18379871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18379871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18379871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18379871pubmed:statusMEDLINElld:pubmed
pubmed-article:18379871pubmed:monthSeplld:pubmed
pubmed-article:18379871pubmed:issn0272-4340lld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:DjuricicSlavi...lld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:MarinkovicTat...lld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:JovanovicMila...lld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:BerisavacIvaIlld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:Milenkovi?San...lld:pubmed
pubmed-article:18379871pubmed:authorpubmed-author:BerisavacIvan...lld:pubmed
pubmed-article:18379871pubmed:issnTypePrintlld:pubmed
pubmed-article:18379871pubmed:volume28lld:pubmed
pubmed-article:18379871pubmed:ownerNLMlld:pubmed
pubmed-article:18379871pubmed:authorsCompleteYlld:pubmed
pubmed-article:18379871pubmed:pagination907-13lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:meshHeadingpubmed-meshheading:18379871...lld:pubmed
pubmed-article:18379871pubmed:year2008lld:pubmed
pubmed-article:18379871pubmed:articleTitleCyclin D1 immunoreactivity in meningiomas.lld:pubmed
pubmed-article:18379871pubmed:affiliationDepartment of Clinical Pathology, Clinical Hospital Centre Zemun, Belgrade, Serbia and Montenegro. kbczemun@afrodita.rcub.bg.ac.yulld:pubmed
pubmed-article:18379871pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:595entrezgene:pubmedpubmed-article:18379871lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18379871lld:entrezgene
lhgdn:association:21883lhgdn:found_inpubmed-article:18379871lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18379871lld:pubmed